Industry: Chemical & Material
Published Date: 2026-05-23
Pages: 134 Pages
Report ld: 5593602
Request Sample
Customized Report
Recombinant Collagen for Cosmetics Market Size(US$)

CAGR 2026-2032
33.7%
Market Size,2032
USD 2,223
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Recombinant Collagen for Cosmetics was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 2223 million, growing at a CAGR of 33.7% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Recombinant Collagen for Cosmetics cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Recombinant collagen refers to the use of recombinant DNA technology to genetically manipulate and (or) modify the genes encoding the desired human collagen protein, and use plasmids or viral vectors to bring the target gene into appropriate host cells (bacteria, yeast or other eukaryotic cells, etc.), express and translate it into collagen or collagen-like polypeptides, and then prepare it through extraction and purification. The use of biosynthesis technology to prepare recombinant collagen can overcome the disadvantages of animal-derived collagen, such as high immunogenicity and viral risks. It is also an important strategy and main way to break through the bottleneck of research and development and application technology of collagen-based medical device products.
Recombinant collagen for cosmetics refers to the functional components of collagen obtained through genetic engineering, microbial fermentation, plant expression or cell culture and added to essence liquid, facial mask, cream, lotion, gel, freeze-dried powder, spray and repair cosmetics. Common types include recombinant type I collagen, recombinant type III collagen, and recombinant type XVII collagen, which are mainly used to moisturize, soothe, film, improve skin barrier, assist in repair and enhance the expression of anti-aging efficacy. In 2025, global Recombinant Collagen for Cosmetics production reached approximately 184 Tons, with an average global market price of around US$ 1,456 per kg.
Recombinant collagen used in cosmetics is in a rapid growth stage, driven mainly by upgraded efficacy skincare, expanded demand for sensitive skin repair, increased consumer awareness of bioactive ingredients, substitution of animal derived collagen, and increased brand demand for high story and high premium ingredients. Compared with traditional animal derived collagen, recombinant collagen has the advantages of controllable source, good batch consistency, low animal source risk, designable molecular structure and more suitable for the construction of efficacy claim system. Therefore, its penetration rate in repair essence, anti-aging facial mask, barrier repair cream, freeze-dried powder and medical art post care cosmetics continues to increase. In terms of competitive landscape, Chinese enterprises are more active in industrialization amplification, terminal brand transformation, and medical beauty and skincare channels. Companies such as Juzi Biotechnology, Jinbo Biotechnology, Chuangjian Medical, and Huaxi Biotechnology have strong market influence, while overseas enterprises are more concentrated in high-end raw materials, biomaterials, and innovative expression systems. In the future, the focus of competition will shift from concept marketing to molecular structure clarity, purity, activity maintenance, formula stability, human efficacy evaluation, compliance claims, and large-scale cost control. Ordinary fragmented raw materials may face downward price and homogenization pressure, while enterprises with high purity, full chain structure, clear efficacy evidence, brand channel binding, and regulatory registration capabilities are more likely to obtain high-end orders.
This report provides a comprehensive view of the global market for Recombinant Collagen for Cosmetics, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Recombinant Collagen for Cosmetics market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Recombinant Collagen for Cosmetics.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Recombinant Collagen for Cosmetics manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Recombinant Collagen for Cosmetics sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Recombinant Collagen for Cosmetics sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Recombinant Collagen for Cosmetics Product Introduction
1.2 Global Recombinant Collagen for Cosmetics Market Size Forecast
1.2.1 Global Recombinant Collagen for Cosmetics Sales Value (2021–2032)
1.2.2 Global Recombinant Collagen for Cosmetics Sales Volume (2021–2032)
1.2.3 Global Recombinant Collagen for Cosmetics Sales Price (2021–2032)
1.3 Recombinant Collagen for Cosmetics Market Trends & Drivers
1.3.1 Recombinant Collagen for Cosmetics Industry Trends
1.3.2 Recombinant Collagen for Cosmetics Market Drivers & Opportunities
1.3.3 Recombinant Collagen for Cosmetics Market Challenges
1.3.4 Recombinant Collagen for Cosmetics Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Recombinant Collagen for Cosmetics Players Revenue Ranking (2025)
2.2 Global Recombinant Collagen for Cosmetics Revenue by Company (2021–2026)
2.3 Global Recombinant Collagen for Cosmetics Sales Volume Ranking of Players (2025)
2.4 Global Recombinant Collagen for Cosmetics Sales Volume by Company (2021–2026)
2.5 Global Recombinant Collagen for Cosmetics Average Price by Company (2021–2026)
2.6 Key Manufacturers Recombinant Collagen for Cosmetics Manufacturing Base and Headquarters
2.7 Key Manufacturers Recombinant Collagen for Cosmetics Product Offerings
2.8 Key Manufacturers Start of Mass Production of Recombinant Collagen for Cosmetics
2.9 Recombinant Collagen for Cosmetics Market Competitive Analysis
2.9.1 Recombinant Collagen for Cosmetics Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Collagen for Cosmetics Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Collagen for Cosmetics revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Recombinant Collagen for Cosmetics Market Classification
3.1 Introduction by Type
3.1.1 Recombinant Type I Collagen
3.1.2 Recombinant Type Ⅲ Collagen
3.1.3 Recombinant Type XVII Collagen
3.1.4 Global Recombinant Collagen for Cosmetics Sales Value by Type
3.1.4.1 Global Recombinant Collagen for Cosmetics Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Recombinant Collagen for Cosmetics Sales Value, by Type (2021–2032)
3.1.4.3 Global Recombinant Collagen for Cosmetics Sales Value, by Type (%), 2021–2032
3.1.5 Global Recombinant Collagen for Cosmetics Sales Volume by Type
3.1.5.1 Global Recombinant Collagen for Cosmetics Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Recombinant Collagen for Cosmetics Sales Volume, by Type (2021–2032)
3.1.5.3 Global Recombinant Collagen for Cosmetics Sales Volume, by Type (%), 2021–2032
3.1.6 Global Recombinant Collagen for Cosmetics Average Price by Type (2021–2032)
3.2 Introduction by Molecular Structure
3.2.1 Full-Chain
3.2.2 Single Chain
3.2.3 Global Recombinant Collagen for Cosmetics Sales Value by Molecular Structure
3.2.3.1 Global Recombinant Collagen for Cosmetics Sales Value by Molecular Structure (2021 vs 2025 vs 2032)
3.2.3.2 Global Recombinant Collagen for Cosmetics Sales Value, by Molecular Structure (2021–2032)
3.2.3.3 Global Recombinant Collagen for Cosmetics Sales Value, by Molecular Structure (%), 2021–2032
3.2.4 Global Recombinant Collagen for Cosmetics Sales Volume by Molecular Structure
3.2.4.1 Global Recombinant Collagen for Cosmetics Sales Volume by Molecular Structure (2021 vs 2025 vs 2032)
3.2.4.2 Global Recombinant Collagen for Cosmetics Sales Volume, by Molecular Structure (2021–2032)
3.2.4.3 Global Recombinant Collagen for Cosmetics Sales Volume, by Molecular Structure (%), 2021–2032
3.2.5 Global Recombinant Collagen for Cosmetics Average Price by Molecular Structure (2021–2032)
3.3 Introduction by Product Form
3.3.1 Liquid
3.3.2 Solid
3.3.3 Global Recombinant Collagen for Cosmetics Sales Value by Product Form
3.3.3.1 Global Recombinant Collagen for Cosmetics Sales Value by Product Form (2021 vs 2025 vs 2032)
3.3.3.2 Global Recombinant Collagen for Cosmetics Sales Value, by Product Form (2021–2032)
3.3.3.3 Global Recombinant Collagen for Cosmetics Sales Value, by Product Form (%), 2021–2032
3.3.4 Global Recombinant Collagen for Cosmetics Sales Volume by Product Form
3.3.4.1 Global Recombinant Collagen for Cosmetics Sales Volume by Product Form (2021 vs 2025 vs 2032)
3.3.4.2 Global Recombinant Collagen for Cosmetics Sales Volume, by Product Form (2021–2032)
3.3.4.3 Global Recombinant Collagen for Cosmetics Sales Volume, by Product Form (%), 2021–2032
3.3.5 Global Recombinant Collagen for Cosmetics Average Price by Product Form (2021–2032)
3.4 Introduction by Purity
3.4.1 Purity≥95%
3.4.2 Purity≥98%
3.4.3 Global Recombinant Collagen for Cosmetics Sales Value by Purity
3.4.3.1 Global Recombinant Collagen for Cosmetics Sales Value by Purity (2021 vs 2025 vs 2032)
3.4.3.2 Global Recombinant Collagen for Cosmetics Sales Value, by Purity (2021–2032)
3.4.3.3 Global Recombinant Collagen for Cosmetics Sales Value, by Purity (%), 2021–2032
3.4.4 Global Recombinant Collagen for Cosmetics Sales Volume by Purity
3.4.4.1 Global Recombinant Collagen for Cosmetics Sales Volume by Purity (2021 vs 2025 vs 2032)
3.4.4.2 Global Recombinant Collagen for Cosmetics Sales Volume, by Purity (2021–2032)
3.4.4.3 Global Recombinant Collagen for Cosmetics Sales Volume, by Purity (%), 2021–2032
3.4.5 Global Recombinant Collagen for Cosmetics Average Price by Purity (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Water Emulsion
4.1.2 Cream
4.1.3 Others
4.2 Global Recombinant Collagen for Cosmetics Sales Value by Application
4.2.1 Global Recombinant Collagen for Cosmetics Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Recombinant Collagen for Cosmetics Sales Value, by Application (2021–2032)
4.2.3 Global Recombinant Collagen for Cosmetics Sales Value, by Application (%), 2021–2032
4.3 Global Recombinant Collagen for Cosmetics Sales Volume by Application
4.3.1 Global Recombinant Collagen for Cosmetics Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Recombinant Collagen for Cosmetics Sales Volume, by Application (2021–2032)
4.3.3 Global Recombinant Collagen for Cosmetics Sales Volume, by Application (%), 2021–2032
4.4 Global Recombinant Collagen for Cosmetics Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Recombinant Collagen for Cosmetics Sales Value by Region
5.1.1 Global Recombinant Collagen for Cosmetics Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Recombinant Collagen for Cosmetics Sales Value by Region (2021–2026)
5.1.3 Global Recombinant Collagen for Cosmetics Sales Value by Region (2027–2032)
5.1.4 Global Recombinant Collagen for Cosmetics Sales Value by Region (%), 2021–2032
5.2 Global Recombinant Collagen for Cosmetics Sales Volume by Region
5.2.1 Global Recombinant Collagen for Cosmetics Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Recombinant Collagen for Cosmetics Sales Volume by Region (2021–2026)
5.2.3 Global Recombinant Collagen for Cosmetics Sales Volume by Region (2027–2032)
5.2.4 Global Recombinant Collagen for Cosmetics Sales Volume by Region (%), 2021–2032
5.3 Global Recombinant Collagen for Cosmetics Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Recombinant Collagen for Cosmetics Sales Value, 2021–2032
5.4.2 North America Recombinant Collagen for Cosmetics Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Recombinant Collagen for Cosmetics Sales Value, 2021–2032
5.5.2 Europe Recombinant Collagen for Cosmetics Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Recombinant Collagen for Cosmetics Sales Value, 2021–2032
5.6.2 Asia Pacific Recombinant Collagen for Cosmetics Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Recombinant Collagen for Cosmetics Sales Value, 2021–2032
5.7.2 South America Recombinant Collagen for Cosmetics Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Recombinant Collagen for Cosmetics Sales Value, 2021–2032
5.8.2 Middle East & Africa Recombinant Collagen for Cosmetics Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Recombinant Collagen for Cosmetics Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Recombinant Collagen for Cosmetics Sales Value and Sales Volume
6.2.1 Key Countries/Regions Recombinant Collagen for Cosmetics Sales Value, 2021–2032
6.2.2 Key Countries/Regions Recombinant Collagen for Cosmetics Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Recombinant Collagen for Cosmetics Sales Value, 2021–2032
6.3.2 United States Recombinant Collagen for Cosmetics Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Recombinant Collagen for Cosmetics Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Recombinant Collagen for Cosmetics Sales Value, 2021–2032
6.4.2 Europe Recombinant Collagen for Cosmetics Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Recombinant Collagen for Cosmetics Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Recombinant Collagen for Cosmetics Sales Value, 2021–2032
6.5.2 China Recombinant Collagen for Cosmetics Sales Value by Type (%), 2025 vs 2032
6.5.3 China Recombinant Collagen for Cosmetics Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Recombinant Collagen for Cosmetics Sales Value, 2021–2032
6.6.2 Japan Recombinant Collagen for Cosmetics Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Recombinant Collagen for Cosmetics Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Recombinant Collagen for Cosmetics Sales Value, 2021–2032
6.7.2 South Korea Recombinant Collagen for Cosmetics Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Recombinant Collagen for Cosmetics Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Recombinant Collagen for Cosmetics Sales Value, 2021–2032
6.8.2 Southeast Asia Recombinant Collagen for Cosmetics Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Recombinant Collagen for Cosmetics Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Recombinant Collagen for Cosmetics Sales Value, 2021–2032
6.9.2 India Recombinant Collagen for Cosmetics Sales Value by Type (%), 2025 vs 2032
6.9.3 India Recombinant Collagen for Cosmetics Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 CollPlant
7.1.1 CollPlant Company Information
7.1.2 CollPlant Introduction and Business Overview
7.1.3 CollPlant Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 CollPlant Recombinant Collagen for Cosmetics Product Offerings
7.1.5 CollPlant Recent Developments
7.2 ProColl
7.2.1 ProColl Company Information
7.2.2 ProColl Introduction and Business Overview
7.2.3 ProColl Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 ProColl Recombinant Collagen for Cosmetics Product Offerings
7.2.5 ProColl Recent Developments
7.3 Gelita AG
7.3.1 Gelita AG Company Information
7.3.2 Gelita AG Introduction and Business Overview
7.3.3 Gelita AG Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Gelita AG Recombinant Collagen for Cosmetics Product Offerings
7.3.5 Gelita AG Recent Developments
7.4 Jellatech
7.4.1 Jellatech Company Information
7.4.2 Jellatech Introduction and Business Overview
7.4.3 Jellatech Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Jellatech Recombinant Collagen for Cosmetics Product Offerings
7.4.5 Jellatech Recent Developments
7.5 HTL Biotechnology
7.5.1 HTL Biotechnology Company Information
7.5.2 HTL Biotechnology Introduction and Business Overview
7.5.3 HTL Biotechnology Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 HTL Biotechnology Recombinant Collagen for Cosmetics Product Offerings
7.5.5 HTL Biotechnology Recent Developments
7.6 Giant Biogene
7.6.1 Giant Biogene Company Information
7.6.2 Giant Biogene Introduction and Business Overview
7.6.3 Giant Biogene Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Giant Biogene Recombinant Collagen for Cosmetics Product Offerings
7.6.5 Giant Biogene Recent Developments
7.7 Shanxi Jinbo Bio-Pharmaceutical
7.7.1 Shanxi Jinbo Bio-Pharmaceutical Company Information
7.7.2 Shanxi Jinbo Bio-Pharmaceutical Introduction and Business Overview
7.7.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Shanxi Jinbo Bio-Pharmaceutical Recombinant Collagen for Cosmetics Product Offerings
7.7.5 Shanxi Jinbo Bio-Pharmaceutical Recent Developments
7.8 Jiangsu JLand Biotech
7.8.1 Jiangsu JLand Biotech Company Information
7.8.2 Jiangsu JLand Biotech Introduction and Business Overview
7.8.3 Jiangsu JLand Biotech Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Jiangsu JLand Biotech Recombinant Collagen for Cosmetics Product Offerings
7.8.5 Jiangsu JLand Biotech Recent Developments
7.9 Jiangsu Chuangjian Medical Technology
7.9.1 Jiangsu Chuangjian Medical Technology Company Information
7.9.2 Jiangsu Chuangjian Medical Technology Introduction and Business Overview
7.9.3 Jiangsu Chuangjian Medical Technology Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Jiangsu Chuangjian Medical Technology Recombinant Collagen for Cosmetics Product Offerings
7.9.5 Jiangsu Chuangjian Medical Technology Recent Developments
7.10 Bloomage Biotech
7.10.1 Bloomage Biotech Company Information
7.10.2 Bloomage Biotech Introduction and Business Overview
7.10.3 Bloomage Biotech Recombinant Collagen for Cosmetics Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Bloomage Biotech Recombinant Collagen for Cosmetics Product Offerings
7.10.5 Bloomage Biotech Recent Developments
8 Industry Chain Analysis
8.1 Recombinant Collagen for Cosmetics Industrial Chain
8.2 Recombinant Collagen for Cosmetics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Recombinant Collagen for Cosmetics Sales Model
8.5.2 Sales Channels
8.5.3 Recombinant Collagen for Cosmetics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Recombinant Collagen for Cosmetics market is projected to grow from US$ 268 million in 2025 to US$ 2223 million by 2032, at a CAGR of 33.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-05-23
Pages: 140
USD 4900.00
(Single User License)
The global Recombinant Collagen for Cosmetics market size was US$ 268 million in 2025 and is forecast to reach a readjusted size of US$ 2223 million by 2032 with a CAGR of 33.7% during the forecast period 2026-2032.
Published Date: 2026-05-23
Pages: 129
USD 4250.00
(Single User License)
The global Recombinant Collagen for Cosmetics market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 2223 million by 2032, at a CAGR of 33.7% from 2026 to 2032.
Published Date: 2026-05-23
Pages: 128
USD 2900.00
(Single User License)
The global Recombinant Collagen for Cosmetics market is projected to grow from US$ 7155 million in 2024 to US$ 18760 million by 2031, at a CAGR of 15.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 167
USD 4900.00
(Single User License)
The global Recombinant Collagen for Cosmetics market size was US$ 7155 million in 2024 and is forecast to a readjusted size of US$ 18760 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 98
USD 4250.00
(Single User License)
The global market for Recombinant Collagen for Cosmetics was estimated to be worth US$ 7155 million in 2024 and is forecast to a readjusted size of US$ 18760 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 125
USD 3950.00
(Single User License)
The global market for Recombinant Collagen for Cosmetics was valued at US$ 7155 million in the year 2024 and is projected to reach a revised size of US$ 18760 million by 2031, growing at a CAGR of 15.0% during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
Valued at US$ 7155 million in 2024, the global Recombinant Collagen for Cosmetics market is forecast to reach US$ 16530 million by 2030, at a CAGR of 15.0% during the forecast period.
Published Date: 2024-12-04
Pages: 162
USD 4900.00
(Single User License)
The global Recombinant Collagen for Cosmetics revenue was US$ 6400 million in 2023 and is forecast to a readjusted size of US$ 16530 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).
Published Date: 2024-12-04
Pages: 137
USD 4350.00
(Single User License)
The global market for Recombinant Collagen for Cosmetics was estimated to be worth US$ 6400 million in 2023 and is forecast to a readjusted size of US$ 16530 million by 2030 with a CAGR of 15.0% during the forecast period 2024-2030.
Published Date: 2024-12-04
Pages: 129
USD 3950.00
(Single User License)
The global Recombinant Collagen for Cosmetics market is projected to grow from US$ 268 million in 2025 to US$ 2223 million by 2032, at a CAGR of 33.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-05-23
Pages: 140
The global Recombinant Collagen for Cosmetics market size was US$ 268 million in 2025 and is forecast to reach a readjusted size of US$ 2223 million by 2032 with a CAGR of 33.7% during the forecast period 2026-2032.
Published: 2026-05-23
Pages: 129
The global Recombinant Collagen for Cosmetics market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 2223 million by 2032, at a CAGR of 33.7% from 2026 to 2032.
Published: 2026-05-23
Pages: 128
The global Recombinant Collagen for Cosmetics market is projected to grow from US$ 7155 million in 2024 to US$ 18760 million by 2031, at a CAGR of 15.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 167
The global Recombinant Collagen for Cosmetics market size was US$ 7155 million in 2024 and is forecast to a readjusted size of US$ 18760 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 98
The global market for Recombinant Collagen for Cosmetics was estimated to be worth US$ 7155 million in 2024 and is forecast to a readjusted size of US$ 18760 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 125
The global market for Recombinant Collagen for Cosmetics was valued at US$ 7155 million in the year 2024 and is projected to reach a revised size of US$ 18760 million by 2031, growing at a CAGR of 15.0% during the forecast period.
Published: 2025-03-10
Pages: 96
Valued at US$ 7155 million in 2024, the global Recombinant Collagen for Cosmetics market is forecast to reach US$ 16530 million by 2030, at a CAGR of 15.0% during the forecast period.
Published: 2024-12-04
Pages: 162
The global Recombinant Collagen for Cosmetics revenue was US$ 6400 million in 2023 and is forecast to a readjusted size of US$ 16530 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).
Published: 2024-12-04
Pages: 137
The global market for Recombinant Collagen for Cosmetics was estimated to be worth US$ 6400 million in 2023 and is forecast to a readjusted size of US$ 16530 million by 2030 with a CAGR of 15.0% during the forecast period 2024-2030.
Published: 2024-12-04
Pages: 129
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now